Article
Directed evolution of a soluble human DR3 receptor for the inhibition of TL1A induced cytokine secretion.
PloS one - 1 Jan 2017
Levin Itay, Zaretsky Marianna, Aharoni Amir
Abstract excerpt
TNF-like 1A (TL1A) is a cytokine belonging to the TNF superfamily that promotes inflammation in autoimmune diseases. Inhibiting the interaction of TL1A with the endogenous death-domain receptor 3 (DR3) offers a therapeutic approach for treating TL1A-induced autoimmune diseases. Here, we generated improved DR3 variants showing increased TL1A binding affinity and stability using a directed evolution approach. Given...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
